Soterios Ltd

1 clinical trials · Sponsor

Record	Firm	Date
A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA) (NCT06402630)	Soterios Ltd	2022-03-23

Every clearance here is in the API, with alerts when new ones post.